Today: 5 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Rocket Lab (RKLB) stock slides 10% as Mars sample-return hopes fade — what investors watch next

Rocket Lab (RKLB) stock slides 10% as Mars sample-return hopes fade — what investors watch next

Rocket Lab shares fell 10% to $73.11 Wednesday, capping a volatile week after Congress cut funding for NASA’s Mars Sample Return mission. The stock hit a session low of $68.56 before recovering slightly in after-hours trading. Investors await Rocket Lab’s February 26 earnings and updates on its Neutron rocket after a recent test failure.
5 February 2026
··
Teradyne stock drops nearly 5% after AI-fueled rally cools, Northland flags valuation

Teradyne stock drops nearly 5% after AI-fueled rally cools, Northland flags valuation

Teradyne shares fell 4.9% to $269.07 at Wednesday’s close, retreating after a sharp post-earnings rally. The company reported a 44% jump in Q4 revenue to $1.083 billion, driven by AI demand, and issued guidance above Wall Street estimates. Northland downgraded the stock on valuation concerns. The drop came as chip stocks slid broadly, with AMD plunging 17% and Nvidia also down.
5 February 2026
·
Johnson & Johnson stock holds near highs as FDA flags Impella heart-pump issue — what to watch next

Johnson & Johnson stock holds near highs as FDA flags Impella heart-pump issue — what to watch next

The FDA issued an early alert on Abiomed Impella RP heart pumps, citing a pressure sensor defect linked to 22 serious injuries but no deaths. Johnson & Johnson shares rose 0.6% to $234.47, holding steady after hours. Traders await further FDA updates and MedTech data at the AF Symposium on Feb. 6. The S&P 500 fell 0.51% while the Dow gained 0.53%.
5 February 2026
··
CrowdStrike stock slides again: AI jitters, insider filings and March earnings loom

CrowdStrike stock slides again: AI jitters, insider filings and March earnings loom

CrowdStrike shares fell 1.5% to $415.36 Wednesday, extending a six-day losing streak and leaving the stock 27% below its November peak. Trading volume hit 4.7 million shares. The drop followed insider sale disclosures and a broader $830 billion selloff in software stocks amid AI disruption fears. Investors now await CrowdStrike’s March 3 earnings report.
5 February 2026
·······
Disney stock closes higher after CEO pick, but the next date on Wall Street’s calendar is March 18

Disney stock closes higher after CEO pick, but the next date on Wall Street’s calendar is March 18

Disney shares rose 2.7% to $107.05 after naming Josh D’Amaro as next CEO, with Bob Iger staying as adviser through 2026. Quarterly revenue climbed 5% to $25.98 billion, but free cash flow fell $2.28 billion after heavy parks investment. The parks unit drove over 70% of operating profit last quarter. Disney warned of a $110 million hit from the YouTube TV carriage suspension.
5 February 2026
··
Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices stock pops as chip dealmaking back in focus ahead of ADI earnings

Analog Devices shares rose 3% to $320.44 Wednesday, bucking declines in major chip stocks. The move followed Texas Instruments’ $7.5 billion deal to buy Silicon Labs, drawing attention to the analog chip sector. Trading volume in ADI topped its recent average. Investors are focused on ADI’s Feb. 18 earnings for signals on demand and margins.
5 February 2026
···
Pfizer stock jumps nearly 4% — what’s driving PFE after the obesity-drug data drop

Pfizer stock jumps nearly 4% — what’s driving PFE after the obesity-drug data drop

Pfizer shares rose 3.9% to $26.78 before holding steady after hours, following new data on its obesity drug PF-3944 and quarterly results. The company maintained its 2026 revenue and earnings outlook but warned of pricing pressures and upcoming patent expirations. Mid-stage trial data showed up to 12.3% weight loss at 28 weeks, with some patients dropping out due to side effects. Trading volume topped 80 million shares.
5 February 2026
·
AST SpaceMobile stock slides 11% after AT&T’s Amazon Leo deal shakes satellite-to-phone trade

AST SpaceMobile stock slides 11% after AT&T’s Amazon Leo deal shakes satellite-to-phone trade

AST SpaceMobile shares fell 10.6% to $103.50 after AT&T announced new agreements with Amazon’s Leo satellite project and AWS. AT&T said the Amazon deal targets fixed broadband for businesses and does not affect its partnership with AST. Investors are watching for updates at Mobile World Congress and the timing of AST’s next satellite launch. Globalstar and Iridium also declined, while AT&T gained 1.5%.
5 February 2026
··
Electronic Arts (EA) stock slips as investors weigh Battlefield 6 momentum against buyout risk

Electronic Arts (EA) stock slips as investors weigh Battlefield 6 momentum against buyout risk

Electronic Arts shares fell 2.3% to $196.84 Wednesday after reporting record quarterly net bookings of $3.05 billion, boosted by strong “Battlefield 6” sales. Net income dropped to $88 million from $293 million a year earlier. EA’s pending $14 billion take-private deal remains on track, with the company skipping its usual earnings call due to the transaction. Trading volume surged to 10.5 million shares, well above average.
5 February 2026
·
Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen stock jumps 8% after earnings beat — what to know before Thursday’s open

Amgen shares surged 8.2% to $366.20 Wednesday after quarterly earnings beat forecasts and the company issued a 2026 outlook above consensus. Investors focused on progress in Amgen’s MariTide obesity program, which could allow less frequent dosing. The company reported Q4 revenue of $9.9 billion and adjusted EPS of $5.29. Amgen plans $2.6 billion in 2026 capital spending and capped share buybacks at $3 billion.
5 February 2026
···
Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola stock steadies after CEO Quincey’s sale filing as Wall Street braces for Feb. 10 results

Coca-Cola closed up 0.6% at $77.35 on Wednesday, steadying after hours as an SEC filing showed CEO James Quincey plans to sell about 337,824 shares worth $25.4 million. Jefferies raised its price target to $88 ahead of next week’s earnings. UBS cited expectations for another “on-algorithm” year. The planned sale represents less than 0.01% of Coke’s outstanding shares.
5 February 2026
··
1 … 101 102 103 104 105 … 688
Go toTop